Results 221 to 228 of about 9,804 (228)

Highlights of the Structure–Activity Relationships of Benzimidazole Linked Pyrrolidines Leading to the Discovery of the Hepatitis C Virus NS5A Inhibitor Pibrentasvir (ABT-530)

Journal of Medicinal Chemistry, 2018
Rolf Wagner, John T Randolph, John K Pratt   +2 more
exaly  

Prevalence and Characterization of NS5A Resistance Associated Variants in Patients who Relapsed following Exposure to NS5A Inhibitors

Journal of Hepatology, 2016
P. Halfon, C. Scholtès, S. Mohamed, G. Penaranda, V. Leroy, M. Bourlière, D. Ouzan, L. Polverel, M.-A. Thélu, F. Zoulim, H. Khiri, S. Larrat   +11 more
openaire   +1 more source

SWITCH TO AROMATASE INHIBITOR BETTER THAN CONTINUING TAMOXIFEN

Ca-A Cancer Journal for Clinicians, 2005
exaly  

A phase 1, randomized, placebo-controlled, 3-day, dose-ranging study of GS-5885, an NS5A inhibitor, in patients with genotype 1 hepatitis C

Journal of Hepatology, 2012
exaly  

Efficacy of Nucleotide Polymerase Inhibitor Sofosbuvir Plus the NS5A Inhibitor Ledipasvir or the NS5B Non-Nucleoside Inhibitor GS-9669 Against HCV Genotype 1 Infection

Gastroenterology, 2014
exaly  

Review for "Ser38-His93-Asn91 triad confers resistance of JFH1 HCV NS5A-Y93H variant to NS5A inhibitors"

2023
openaire   +1 more source

Distinct Functions of NS5A in Hepatitis C Virus RNA Replication Uncovered by Studies with the NS5A Inhibitor BMS-790052

Journal of Virology, 2011
exaly  

Discovery of ravidasvir (PPI-668) as a potent pan-genotypic HCV NS5A inhibitor

Bioorganic and Medicinal Chemistry Letters, 2016
exaly